“End-to-End” Strategies Achieve Better Enrollment, Diversity, and Data Collection in Clinical Trials
The revolution in cancer drug development has a caveat: Only a fraction of eligible patients take part in clinical trials. Historically, findings from studies estimate that the share of eligible ...
Generative AI is rapidly reshaping health systems, offering innovative solutions to enhance care delivery, operational efficiency, and health equity. From automating workflows and improving patient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results